GISP Profiles, 2008
Figure A Data - Age of GISP Participants
Figure B Data - Race/Ethnicity of GISP Participants
Figure C Data - Percentage of GISP Participants Identifying as Men Who Have Sex with Men, 1999-2008
Figure D Data - Reason for Visit Among GISP Participants
Figure E Data - Previous Episode of Gonorrhea Among GISP Participants, 1991-2008
Figure F Data - Drugs Used to Treat Gonorrhea Among GISP Participants
Figure G Data - Drugs Used to Treat Chlamydia Trachomatis Infection Among GISP Participants
Figure H Data - Resistance to Penicillin, Tetracycline, and Ciprofloxacin Among GISP Isolates
Figure I Data - Decreased Susceptibility to Ceftriaxone Among GISP Isolates, 1990-2008
Figure J Data - Decreased Susceptibility to Cefixime Among GISP Isolates, 1992-2006
Figure K Data - Intermediate Resistance and Resistance to Ciprofloxacin Among GISP Isolates, 1990-2008
Figure L Data - Decreased Susceptibility to Azithromycin Among GISP Isolates, 1990-2008
The Gonococcal Isolate Surveillance Project (GISP), a national sentinel surveillance system, was established in 1986 to monitor trends in antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in the United States among selected sexually transmitted diseases (STD) clinics in approximately 25-30 GISP sentinel sites.
The following site-specific profiles consist of figures depicting the demographic and clinical data of the men with gonorrhea enrolled in GISP and the antimicrobial susceptibility results of the Neisseria gonorrhoeae isolates submitted.
Print all profiles (5MB)